Our professionals

Imagen del Dr. José Luis del Pozo León, especialista en Microbiología Clínica de la Clínica Universidad de Navarra.

Dr. José Luis del Pozo

Director of the Infectious Diseases Department and the Microbiology Department.
Specialist in Clinical Microbiology. Fellow in Infectious Diseases (USA, 2006-2009).
Primary dedication to the diagnosis and treatment of patients with infectious diseases, both in the outpatient clinic and on the inpatient ward

Works at: Navarre headquarters
Make an appointment
Be part of: Clínica Universidad de Navarra
INDEX H 33

Professional career

Medical degree from the University of Navarra (1995).

Specialty training in Microbiology and Parasitology via MIR in the Microbiology Department of the Clínica Universitaria de Navarra (1997-2001).

From October 2006 to May 2009 (32 months), postdoctoral stay in the Division of Infectious Diseases at Mayo Clinic College of Medicine in Rochester, Minnesota (USA), where he completed a Research Fellowship in Infectious Diseases. During this period, he participated in four research projects related to biomedical device-associated infections (two from Mayo Clinic Center for Translational Sciences Activities: Proposal for the CR Protocol and CR20 program, one from the National Institutes of Health, USA, and another from a Medical Research Foundation).

In May 2007, he obtained the Certificate of Training in Molecular Biological Techniques in the Department of Molecular Biology, and from June 2008 to June 2009 he completed the Certificate in Clinical Research at the Center for Translational Science Activities at Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

University Expert Diploma in Vaccines in Clinical Practice. School of Medicine, Complutense University of Madrid. June 2014

He is currently Director of the Infectious Diseases Department and the Microbiology Department of the Clínica Universidad de Navarra, where he carries out his inpatient clinical activity. 

He has been Chair of the Infectious Diseases Committee of the Clínica Universidad de Navarra since 2016.

RESEARCH AREAS

  • He has participated in more than 10 research projects as Principal Investigator: Mayo Clinic Center for Translational Sciences Activities (Proposal for the CR Protocol and CR20 program), national agency (FIS), Strategic Singular Project of the Ministry of Science and Innovation, Fundación CAN, and the University of Navarra Research Plan. He has participated in more than 20 national and international funded research projects as a member of the research team.
  • He has served as Principal Investigator on two research contracts with companies (Novartis and AMES Sintered Metallic Components). Director of the Microbial Biofilms Laboratory of the Clínica Universidad de Navarra since 2009.
  • He has participated as a researcher in 6 clinical trials.
  • Principal Investigator at IdiSNA (Navarra Health Research Institute) of the Prevention and Control of Infectious Diseases group (Code 506) within the Inflammatory, Immune, and Infectious Diseases Area since 2016.
  • Coordinator of the Inflammatory, Immune, and Infectious Diseases Area of IdiSNA (Navarra Health Research Institute) from July 2022 to the present.
  • Member of the Internal Scientific Committee of IdiSNA (Navarra Health Research Institute) appointed by the Board of Trustees of the Fundación Instituto de Investigacion Sanitaria de Navarra from July 2022 to the present.
  • He is part of the Technical Advisory Committee for Epidemiological Surveillance and Infection Control of Navarra since May 2017. Foral Order 387E/2017 of April 21 of the Minister of Health creating the Technical Advisory Committee for Surveillance and Infection Control of Navarra (BON, May 19, 2017).
  • Established Researcher at the Instituto de Investigación Sanitaria La Fe de Valencia within the Multidisciplinary Group for the Study of Severe Infection since 2011.
  • Member of the Editorial Board of the Journal of Clinical Microbiology since 2011. Evaluator for the Agencia Nacional de Evaluación y Prospectiva (ANEP) of the Ministry of Science and Innovation since 2010. He is part of the Project Evaluation Panel for the Infectious Diseases area of the Health Research Fund, Instituto de Salud Carlos III.

AREAS OF INTEREST

  1. New strategies in the diagnosis and treatment of biomedical device-associated infections.
  2. Bioengineering for the diagnosis and treatment of biomedical device-associated infections.
  3. Diagnosis and treatment of healthcare-associated infections.
  4. New strategies for control of malaria.
  5. Prevention, diagnosis, and treatment of SARS-CoV-2 infection.

Activity

In teaching

  • Full Professor at the School of Medicine of the University of Navarra (Mechanisms of Disease by Living Agents, Medical Identity).
  • Deputy Director of the Department of Microbiology of the School of Medicine of the University of Navarra.
  • He has three six-year research terms recognized by the Comisión Nacional Evaluadora de la Actividad Investigadora (Years: 2003-2008, 2009-2014, and 2015-2020), in accordance with the Collaboration Agreement signed between the University of Navarra and the Secretaría General de Universidades in October 2012 (CNEAI Advisory Committee No. 04 with identification number 02530206E04).
  • Researcher in 7 Educational Innovation Projects.
  • Patron of the University of Navarra cooperation for development congress Balmis & Zendal during the years 2020-2021-2022 and 2023.

In research

  • Author of 160 publications in journals indexed in PubMed. In more than 70% of them, he appears as first author or senior author (last author and corresponding author). Forty percent of these works have been published in first-quartile journals, including New England Journal of Medicine, Lancet, Lancet Infectious Diseases, Clinical Infectious Diseases, Clinical Microbiology Reviews, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Mayo Clinic Proceedings, and Malaria Journal.
  • Co-author of more than 40 books or book chapters.
  • He has supervised eight doctoral dissertations (one of them international), and currently supervises three more.
  • He has supervised 16 final-year medical degree projects and one master’s thesis. He has served on more than 30 doctoral dissertation examination committees.
  • Author/co-author of more than 250 presentations at national and international conferences. He has delivered more than 300 invited lectures at national and international conferences, seminars, and symposia in hospitals and research centers.
  • He served as President of the Study Group on Healthcare-Associated Infection (GEIRAS-SEIMC) until 2020 and is currently Secretary of the Study Group on Osteoarticular Infection (GEIO-SEIMC).